Navigation Links
MedImmune Initiates Phase 2a Multi-Dose Study in Patients with Asthma
Date:8/19/2007

one of at least 29 naturally occurring interleukins in the human body. Overexpression of IL-9 in animal models has been shown to result in many features of asthma, including increased airway inflammation and hyperreactivity. Blocking the actions of IL-9 has been shown to reduce the airway inflammation and increased airway inflammation and increased airway hyperresponsiveness seen in animal models of asthma. MedImmune is conducting research to evaluate the potential to use MAbs targeting IL-9 to treat or prevent symptomatic, moderate-to-severe, persistent asthma.

About Asthma

Asthma is a chronic disease of the airways that may cause wheezing, breathlessness, chest tightness and coughing. According to the U.S. Centers for Disease Control and Prevention (CDC), more than 30 million Americans reported having a history of asthma in 2003, including 9 million children. About 20 million said they currently had asthma. In 2000, the CDC reported that there were more than 10 million asthma-related outpatient visits to private physician offices and hospital clinics. The National Institutes of Health (NIH) have estimated asthma-related healthcare costs in the U.S. at $14 billion annually.

About MedImmune, Inc.

MedImmune strives to provide better medicines to patients, new medical options for physicians and rewarding careers to employees. Dedicated to advancing science and medicine to help people live better lives, the company is focused on the areas of infectious diseases, cancer and inflammatory diseases. With more than 3,000 employees worldwide, MedImmune is headquartered in Maryland. For more information, visit the company's website at http://www.medimmune.com .


'/>"/>
SOURCE MedImmune, Inc.

Copyright©2007 PR Newswire.

1

GOOD

Page: 1 2

Related medicine technology :

1. Infinity and MedImmune Present Updated Phase I Results of IPI-504 in GIST at ASCO Annual Meeting
2. Infinity and MedImmune Announce Updated Data On Ipi-504 to be Presented At ASCO
3. MedImmune Highlights Advances in Inflammatory Disease Pipeline With Series of Data Presentations
4. MedImmune Announces Positive Clinical Results at PAS Annual Meeting From Large Prospective Trial in Prevention of Serious RSV Disease
5. Pediatric Academic Societies Annual Meeting to Feature Data Presentations Related to MedImmune Clinical Programs in Influenza, RSV and hMPV
6. Micromet Achieves Milestone in BiTE Research Collaboration with MedImmune
7. MedImmune Publishes New Data in Nature Immunology Demonstrating The Role HMGB1 May Play in Systemic Autoimmune Diseases
8. MedImmune and Micromet Publish Data on Novel Anti-Cancer BiTE Molecule
9. Micromet and MedImmune Present Data From Preclinical Study of New BiTE Molecule Targeting CEA
10. Infinity and MedImmune to Present Preclinical Data From Study of Oral Formulation of IPI-504 At AACR
11. Malvern initiates European user group meetings for chemical imaging
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... , May 21, 2013  IsoRay, Inc. (AMEX: ... it has entered into an exclusive international distribution agreement ... product line in Greece . IsoRay ... brachytherapy and medical radioisotope applications for brain cancer, lung ... ("gyn") cancer. IASIS Medical is ideally ...
(Date:5/21/2013)... , May 21, 2013 iHealth Lab ... of wireless personal healthcare products and a powerful ... announcing the release of two new fitness products ... monitors and scales: the Wireless Pulse Oximeter and ... http://photos.prnewswire.com/prnh/20130521/SF17618 ) iHealth Lab ...
(Date:5/21/2013)...  The North Shore-LIJ Health System is expanding a ... at North Shore University Hospital in Manhasset, ... at Forest Hills (NY) Hospital. ... new pilot program strengthens patient safety by providing hospitals ... first time in the US that remote video auditing ...
Breaking Medicine Technology:IsoRay Announces A New International Distributor For Greece 2IsoRay Announces A New International Distributor For Greece 3iHealth Lab adds new products and partners to mobile personal healthcare offering 2iHealth Lab adds new products and partners to mobile personal healthcare offering 3North Shore-LIJ Extends Use of 3rd Party Remote Video Auditing into ORs 2North Shore-LIJ Extends Use of 3rd Party Remote Video Auditing into ORs 3North Shore-LIJ Extends Use of 3rd Party Remote Video Auditing into ORs 4
... 2011 Caliper Life Sciences, Inc. (NASDAQ: ... for life science companies, today announced that Kevin Hrusovsky, President ... BioConference Live event, which was held on October 26, and ... Forum on October 27 held at Harvard Medical School. ...
... Conn., Nov. 7, 2011 Boehringer Ingelheim Pharmaceuticals, Inc. ... a Phase 2b study, SOUND-C2, that showed the combination ... compounds – the protease inhibitor BI 201335 and the ... successful in reducing viral load below the lower limit ...
Cached Medicine Technology:Caliper CEO Kevin Hrusovsky Presented Vision for Revolutionizing Medicine 2Positive Interim Results from Interferon-Free Phase 2b SOUND-C2 Study with Boehringer Ingelheim's Two Investigational HCV Direct Acting Antivirals Presented at AASLD 2Positive Interim Results from Interferon-Free Phase 2b SOUND-C2 Study with Boehringer Ingelheim's Two Investigational HCV Direct Acting Antivirals Presented at AASLD 3Positive Interim Results from Interferon-Free Phase 2b SOUND-C2 Study with Boehringer Ingelheim's Two Investigational HCV Direct Acting Antivirals Presented at AASLD 4Positive Interim Results from Interferon-Free Phase 2b SOUND-C2 Study with Boehringer Ingelheim's Two Investigational HCV Direct Acting Antivirals Presented at AASLD 5
(Date:5/21/2013)... HealthDay Reporter , , TUESDAY, May 21 (HealthDay News) ... but some of the changes brought about by the ... New research has found that people with diabetes ... higher risk of having a severe low blood sugar ... to people with diabetes who aren,t depressed. ...
(Date:5/21/2013)... charged gold nanoparticles are usually toxic to cells, ... toxicity. Mayo Clinic researchers found out why, and ... ovarian cancer cells. The discovery is detailed in ... of Biological Chemistry ., "This study identifies a ... preventing the cell death or apoptosis which should ...
(Date:5/21/2013)... The team at Comfort &Harmony™, a leader in nurturing baby ... nursing pillow. , Nursing pillows are designed for ... , In a nursing pillow, important things to look ... at Comfort & Harmony, kept this list in mind when ... needs to fit a mom’s body and feel comfortable. Some ...
(Date:5/21/2013)... May 21, 2013 Vyopta Incorporated, ... automation applications for video collaboration, today announced the ... index evaluates key performance metrics related to quality, ... immediate, aggregated indicator of the performance of their ... Vyopta vAnalytics™ application, the vRating™ delivers high level ...
(Date:5/21/2013)... Ohio universities and four hospitals have joined with the ... research program aimed exclusively at finding the unknown causes ... invest $10 million in the program over five years. ... -- Ohio Collaborative is a unique research enterprise," says ... Dimes. "This new transdisciplinary, team-based research model will leverage ...
Breaking Medicine News(10 mins):Health News:Depression May Raise Low Blood Sugar Risk in Diabetics 2Health News:Depression May Raise Low Blood Sugar Risk in Diabetics 3Health News:Mayo Clinic: How gold nanoparticles can help fight ovarian cancer 2Health News:Comfort and Harmony™ Shares Tips on What to Look for in a Nursing Pillow 2Health News:Comfort and Harmony™ Shares Tips on What to Look for in a Nursing Pillow 3Health News:New vRating™ Video and Unified Communications Scoring System Delivers Innovative Approach to Measure Performance and ROI for Collaboration Networks 2Health News:New vRating™ Video and Unified Communications Scoring System Delivers Innovative Approach to Measure Performance and ROI for Collaboration Networks 3Health News:New multi-million dollar research center aims to solve the mystery of premature birth 2Health News:New multi-million dollar research center aims to solve the mystery of premature birth 3
... getting the medications they need, researchers say , , MONDAY, ... American children have attention-deficit/hyperactivity disorder (ADHD), but only 32 ... , That,s the sobering conclusion of a landmark new ... doctors consider the "gold standard" of diagnostic criteria -- ...
... Stock in the SDAX as Per September 6, 2007 ... Outside the Normal Schedule, ... September, DÜSSELDORF, Germany, September 3 Gerresheimer AG has,been listed in ... one of the largest IPOs of the year, with a total,issue volume ...
... Belgium, September 3 KFH has announced that ... ISO 13485 and ISO,9001:2000 quality management systems with ... Dr Sally Sennitt, MD, says: "We are delighted,to ... systems,through working with BSI. It is a major ...
... year-round consumption of fresh leafy greens such as lettuce ... produce free from contamination by food poisoning bacteria, according ... at the Society for General Microbiologys 161st Meeting at ... September 2007. , The only land suitable for supplying ...
... treatment of schizophrenia, INDIANAPOLIS, Sept. 2 An ... Medicine,demonstrates that for the first time in humans a ... mGlu2/3 has antipsychotic activity. The study,was sponsored by Eli ... this study - a randomized, double-blind, placebo-controlled clinical,trial - ...
... buzzing with electrical activity created by sodium and potassium ... pores. To prevent the constant chatter from descending into ... be tightly regulated. , One possibility is to ... dumpster, discovered researchers at the Salk Institute for Biological ...
Cached Medicine News:Health News:9% of U.S. Kids Have ADHD 2Health News:9% of U.S. Kids Have ADHD 3Health News:Lettuce, leafy greens and E. coli 2Health News:Investigational Agent Targeting Metabotropic Glutamate 2/3 Receptors Demonstrates Antipsychotic Activity in Humans, Study in Nature Medicine Finds 2Health News:Investigational Agent Targeting Metabotropic Glutamate 2/3 Receptors Demonstrates Antipsychotic Activity in Humans, Study in Nature Medicine Finds 3Health News:Investigational Agent Targeting Metabotropic Glutamate 2/3 Receptors Demonstrates Antipsychotic Activity in Humans, Study in Nature Medicine Finds 4Health News:Investigational Agent Targeting Metabotropic Glutamate 2/3 Receptors Demonstrates Antipsychotic Activity in Humans, Study in Nature Medicine Finds 5Health News:Investigational Agent Targeting Metabotropic Glutamate 2/3 Receptors Demonstrates Antipsychotic Activity in Humans, Study in Nature Medicine Finds 6Health News:A drug-sensitive 'traffic cop' tells potassium channels to get lost 2
... Room Knee Brace frees the ... the time-consuming post-op fitting and ... more complex brace designs. The ... provides the same benefits as ...
... and Cronin, Inc. is ... Patient Footwear, Orthopedic Softgoods, ... Products. Our products are ... and available in the ...
... and Cronin, Inc. is ... Patient Footwear, Orthopedic Softgoods, ... Products. Our products are ... and available in the ...
SofTec Genu is the first functional brace that provides full soft tissue control, enhances natural muscle movement, prevents atrophy, increases proprioception and controls A/P laxity....
Medicine Products: